(BKR) Baker Hughes - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US05722G1004
Stock: Oilfield Equipment, Energy Services, Industrial Technology, Gas Technology
Total Rating 61
Risk 65
Buy Signal -0.02
| Risk 5d forecast | |
|---|---|
| Volatility | 33.9% |
| Relative Tail Risk | -6.98% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 14.50 |
| Character TTM | |
|---|---|
| Beta | 1.040 |
| Beta Downside | 1.648 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.00% |
| CAGR/Max DD | 1.07 |
EPS (Earnings per Share)
Revenue
Description: BKR Baker Hughes March 05, 2026
Baker Hughes Co. (BKR) provides technology and services across the energy and industrial sectors. The company operates in two primary segments: Oilfield Services & Equipment and Industrial & Energy Technology.
The Oilfield Services & Equipment segment offers a comprehensive range of products and services for oil and gas operations, from exploration to decommissioning. This includes drilling services, artificial lift systems, and subsea equipment. The oilfield services sector is cyclical, heavily influenced by global commodity prices and capital expenditure by exploration and production companies.
The Industrial & Energy Technology segment supplies gas technology equipment, such as turbines and compressors, and related aftermarket services. It also provides non-destructive testing, flow control solutions, and digital software for asset optimization. This segment serves a broad industrial customer base, including power generation and processing plants, indicating diversification beyond direct oil and gas extraction.
For more detailed financial analysis and performance metrics, ValueRay offers in-depth research tools.
Headlines to watch out for
- Oil and gas capital expenditure directly impacts equipment and service demand
- Global energy transition affects industrial technology segment growth
- Commodity price volatility influences exploration and production spending
- Supply chain disruptions increase manufacturing costs
- Regulatory changes in oil and gas impact operational expenses
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.85 > 1.0 |
| NWC/Revenue: 17.85% < 20% (prev 15.16%; Δ 2.69% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.81b > Net Income 2.59b |
| Net Debt (3.43b) to EBITDA (4.29b): 0.80 < 3 |
| Current Ratio: 1.36 > 1.5 & < 3 |
| Outstanding Shares: last quarter (994.0m) vs 12m ago -0.50% < -2% |
| Gross Margin: 23.60% > 18% (prev 0.21%; Δ 2.34k% > 0.5%) |
| Asset Turnover: 69.99% > 50% (prev 72.54%; Δ -2.55% > 0%) |
| Interest Coverage Ratio: 13.96 > 6 (EBITDA TTM 4.29b / Interest Expense TTM 222.0m) |
Altman Z'' 0.82
| A: 0.12 (Total Current Assets 18.83b - Total Current Liabilities 13.88b) / Total Assets 40.88b |
| B: -0.08 (Retained Earnings -3.25b / Total Assets 40.88b) |
| C: 0.08 (EBIT TTM 3.10b / Avg Total Assets 39.62b) |
| D: -0.22 (Book Value of Equity -4.92b / Total Liabilities 21.87b) |
| Altman-Z'' Score: 0.82 = B |
Beneish M -3.25
| DSRI: 0.94 (Receivables 6.64b/7.12b, Revenue 27.73b/27.83b) |
| GMI: 0.89 (GM 23.60% / 20.99%) |
| AQI: 0.94 (AQ_t 0.39 / AQ_t-1 0.42) |
| SGI: 1.00 (Revenue 27.73b / 27.83b) |
| TATA: -0.03 (NI 2.59b - CFO 3.81b) / TA 40.88b) |
| Beneish M-Score: -3.25 (Cap -4..+1) = AA |
What is the price of BKR shares?
As of March 18, 2026, the stock is trading at USD 57.00 with a total of 11,939,594 shares traded.
Over the past week, the price has changed by -3.94%, over one month by -4.78%, over three months by +26.33% and over the past year by +32.53%.
Over the past week, the price has changed by -3.94%, over one month by -4.78%, over three months by +26.33% and over the past year by +32.53%.
Is BKR a buy, sell or hold?
Baker Hughes has received a consensus analysts rating of 4.26.
Therefore, it is recommended to buy BKR.
- StrongBuy: 12
- Buy: 10
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BKR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.4 | 7.7% |
| Analysts Target Price | 61.4 | 7.7% |
BKR Fundamental Data Overview March 14, 2026
P/E Trailing = 21.5
P/E Forward = 21.7865
P/S = 1.9919
P/B = 3.0942
P/EG = 3.0256
Revenue TTM = 27.73b USD
EBIT TTM = 3.10b USD
EBITDA TTM = 4.29b USD
Long Term Debt = 5.40b USD (from longTermDebt, last quarter)
Short Term Debt = 862.0m USD (from shortTermDebt, last quarter)
Debt = 7.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.43b USD (from netDebt column, last quarter)
Enterprise Value = 57.43b USD (55.24b + Debt 7.14b - CCE 4.96b)
Interest Coverage Ratio = 13.96 (Ebit TTM 3.10b / Interest Expense TTM 222.0m)
EV/FCF = 22.63x (Enterprise Value 57.43b / FCF TTM 2.54b)
FCF Yield = 4.42% (FCF TTM 2.54b / Enterprise Value 57.43b)
FCF Margin = 9.15% (FCF TTM 2.54b / Revenue TTM 27.73b)
Net Margin = 9.33% (Net Income TTM 2.59b / Revenue TTM 27.73b)
Gross Margin = 23.60% ((Revenue TTM 27.73b - Cost of Revenue TTM 21.19b) / Revenue TTM)
Gross Margin QoQ = 23.73% (prev 24.27%)
Tobins Q-Ratio = 1.40 (Enterprise Value 57.43b / Total Assets 40.88b)
Interest Expense / Debt = 0.85% (Interest Expense 61.0m / Debt 7.14b)
Taxrate = 8.79% (253.0m / 2.88b)
NOPAT = 2.83b (EBIT 3.10b * (1 - 8.79%))
Current Ratio = 1.36 (Total Current Assets 18.83b / Total Current Liabilities 13.88b)
Debt / Equity = 0.38 (Debt 7.14b / totalStockholderEquity, last quarter 18.83b)
Debt / EBITDA = 0.80 (Net Debt 3.43b / EBITDA 4.29b)
Debt / FCF = 1.35 (Net Debt 3.43b / FCF TTM 2.54b)
Total Stockholder Equity = 17.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.53% (Net Income 2.59b / Total Assets 40.88b)
RoE = 14.43% (Net Income TTM 2.59b / Total Stockholder Equity 17.93b)
RoCE = 13.28% (EBIT 3.10b / Capital Employed (Equity 17.93b + L.T.Debt 5.40b))
RoIC = 11.79% (NOPAT 2.83b / Invested Capital 23.98b)
WACC = 8.72% (E(55.24b)/V(62.39b) * Re(9.75%) + D(7.14b)/V(62.39b) * Rd(0.85%) * (1-Tc(0.09)))
Discount Rate = 9.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.80%
[DCF] Terminal Value 77.08% ; FCFF base≈2.34b ; Y1≈2.60b ; Y5≈3.40b
[DCF] Fair Price = 48.40 (EV 51.26b - Net Debt 3.43b = Equity 47.84b / Shares 988.2m; r=8.72% [WACC]; 5y FCF grow 12.72% → 2.90% )
EPS Correlation: 86.16 | EPS CAGR: 55.22% | SUE: 2.22 | # QB: 3
Revenue Correlation: 87.59 | Revenue CAGR: 11.96% | SUE: 1.36 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.61 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=-5 | Analysts=18
EPS current Year (2026-12-31): EPS=2.57 | Chg7d=-0.011 | Chg30d=-0.006 | Revisions Net=+3 | Growth EPS=-1.2% | Growth Revenue=-1.1%
EPS next Year (2027-12-31): EPS=2.91 | Chg7d=+0.000 | Chg30d=+0.014 | Revisions Net=-1 | Growth EPS=+13.2% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: -0.56 (2 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 9.8% - Earnings Yield 4.7%)
[Growth] Growth Spread = -8.1% (Analyst -3.0% - Implied 5.1%)
P/E Forward = 21.7865
P/S = 1.9919
P/B = 3.0942
P/EG = 3.0256
Revenue TTM = 27.73b USD
EBIT TTM = 3.10b USD
EBITDA TTM = 4.29b USD
Long Term Debt = 5.40b USD (from longTermDebt, last quarter)
Short Term Debt = 862.0m USD (from shortTermDebt, last quarter)
Debt = 7.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.43b USD (from netDebt column, last quarter)
Enterprise Value = 57.43b USD (55.24b + Debt 7.14b - CCE 4.96b)
Interest Coverage Ratio = 13.96 (Ebit TTM 3.10b / Interest Expense TTM 222.0m)
EV/FCF = 22.63x (Enterprise Value 57.43b / FCF TTM 2.54b)
FCF Yield = 4.42% (FCF TTM 2.54b / Enterprise Value 57.43b)
FCF Margin = 9.15% (FCF TTM 2.54b / Revenue TTM 27.73b)
Net Margin = 9.33% (Net Income TTM 2.59b / Revenue TTM 27.73b)
Gross Margin = 23.60% ((Revenue TTM 27.73b - Cost of Revenue TTM 21.19b) / Revenue TTM)
Gross Margin QoQ = 23.73% (prev 24.27%)
Tobins Q-Ratio = 1.40 (Enterprise Value 57.43b / Total Assets 40.88b)
Interest Expense / Debt = 0.85% (Interest Expense 61.0m / Debt 7.14b)
Taxrate = 8.79% (253.0m / 2.88b)
NOPAT = 2.83b (EBIT 3.10b * (1 - 8.79%))
Current Ratio = 1.36 (Total Current Assets 18.83b / Total Current Liabilities 13.88b)
Debt / Equity = 0.38 (Debt 7.14b / totalStockholderEquity, last quarter 18.83b)
Debt / EBITDA = 0.80 (Net Debt 3.43b / EBITDA 4.29b)
Debt / FCF = 1.35 (Net Debt 3.43b / FCF TTM 2.54b)
Total Stockholder Equity = 17.93b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.53% (Net Income 2.59b / Total Assets 40.88b)
RoE = 14.43% (Net Income TTM 2.59b / Total Stockholder Equity 17.93b)
RoCE = 13.28% (EBIT 3.10b / Capital Employed (Equity 17.93b + L.T.Debt 5.40b))
RoIC = 11.79% (NOPAT 2.83b / Invested Capital 23.98b)
WACC = 8.72% (E(55.24b)/V(62.39b) * Re(9.75%) + D(7.14b)/V(62.39b) * Rd(0.85%) * (1-Tc(0.09)))
Discount Rate = 9.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.80%
[DCF] Terminal Value 77.08% ; FCFF base≈2.34b ; Y1≈2.60b ; Y5≈3.40b
[DCF] Fair Price = 48.40 (EV 51.26b - Net Debt 3.43b = Equity 47.84b / Shares 988.2m; r=8.72% [WACC]; 5y FCF grow 12.72% → 2.90% )
EPS Correlation: 86.16 | EPS CAGR: 55.22% | SUE: 2.22 | # QB: 3
Revenue Correlation: 87.59 | Revenue CAGR: 11.96% | SUE: 1.36 | # QB: 1
EPS next Quarter (2026-06-30): EPS=0.61 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=-5 | Analysts=18
EPS current Year (2026-12-31): EPS=2.57 | Chg7d=-0.011 | Chg30d=-0.006 | Revisions Net=+3 | Growth EPS=-1.2% | Growth Revenue=-1.1%
EPS next Year (2027-12-31): EPS=2.91 | Chg7d=+0.000 | Chg30d=+0.014 | Revisions Net=-1 | Growth EPS=+13.2% | Growth Revenue=+4.7%
[Analyst] Revisions Ratio: -0.56 (2 Up / 7 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.1% (Discount Rate 9.8% - Earnings Yield 4.7%)
[Growth] Growth Spread = -8.1% (Analyst -3.0% - Implied 5.1%)